Yossi Gaspar
Analyst · Alembic Global. Please go ahead
Thank you Rami. Hello everyone and thank you for joining us today. As Rami mentioned on April 1, Kobi Kagan will take over as Chief Financial Officer. I will continue as CEO, Executive Vice-President Business Management and would retain among corporate wide duties the responsibility for capital market investor relations working together with Rami. I look forward to introducing Kobi to investors and analysts over the coming weeks and months. I would like to take this opportunity to wish Kobi good luck and success in his new role. The 2021 annual results reflect the very positive transformation of Elbit over the last few years, during which we successfully moved up the value chain from a provider of products and systems to a provider of comprehensive solutions. The Hellenic flight school contract is a good example of a comprehensive contract as a result of this transformation, as well as supports the growth in order backlog and revenues that indicate the strong demand for our systems and solutions. We continue to implement mitigation plans to limit the impact of the strengthening Israeli shekel and the competition for talent. In the short term, these include the adoption of rolling currency hedge policy and efficiency measures. Over the longer term, we plan to expand our engineering and manufacturing footprint in high quality low cost countries to better balance our currency exposure and reduce risk. The introduction of a company-wide ERP system will support these ends. I will now highlight and discuss some of the key figures and trends in our financial results. First quarter revenues were $1,494 million and increased by 8.5% year-over-year. For 2021 as a whole, our revenues were $5.3 billion versus $4.7 billion last year, representing a growth of 13%. A major part of the growth was organic in addition to the contribution from Sparton, which we acquired in the second quarter of 2021. In terms of annual revenue breakdown across our areas of operation, airborne systems accounted for 38% of total annual revenues and increased year-over-year mainly due to airborne precision-guided munition sales. Land systems sales accounted for 24% of total revenues, a similar level to the revenues for 2020. C4ISR at 26% of revenues increased year-over-year, primarily due to the acquisition of Sparton and unmanned systems sales. Electro-optics accounted for 9% of total sales and other sales were 4% of revenues and increased year-over-year mainly due to the gross of our U.S. medical instrumentation subsidiaries. Our diverse geographic revenue base is important to the long-term sustainability of our business. In 2021 North America contributed to 31% of our revenues; Asia Pacific 27%; Israel was 21% and Europe 17%. The growth in U.S. was mainly due to the Sparton acquisition and sales of commercial medical instrumentation. Asia-Pacific revenues increased mainly due to sales of precision-guided munitions and Unmanned Airborne Systems. The growth in European revenues was primarily to training and simulation sales. Elbit has always viewed Europe as a strategically important market with significant potential. We have made significant investments to expand our positions across the continent. Since 2014, our European revenues increased by more than 90% significantly faster than the growth of the European NATO members’ defense budgets in the same period. Almost all of this growth was organic. Following many years of investment, we believe Elbit is well positioned to benefit from the planned increase in the European defense spending. Compared with the fourth quarter last year, we saw strong growth in Asia Pacific that more than offset losses in certain other markets. This reflects the phasing of programs and trends to fluctuate from quarter-to-quarter. We believe the longer term trends are more representative of our business. The non-GAAP gross margin for the fourth quarter was 25.5%, compared with the fourth quarter of 2020 at 26.3%. For the full year of 2021, non-GAAP gross margin was 26.2% compared with 26.7% last year. Non-GAAP gross margin in 2021 reflect an unfavorable program mix as well as the impact of a strong shekel the U.S. dollar compared to 2020. GAAP gross margin in the fourth quarter of 2021 was 25.1% of revenues compared to 26% in the fourth quarter of 2020. GAAP gross margin in 2021 was 25.7% compared with 35% in 2020. GAAP gross profit in 2020 included expenses of approximately $60 million as a result of a non-cash expense related to inventory write-offs, and asset impairment mainly in our commercial aviation activities, due to the impact of the COVID-19. The fourth quarter non-GAAP operating income was $120 million or 8% of revenues, compared with $113.8 million or 8.3% of revenues last year. Margin has declined slightly year-over-year due to lower gross margins and higher G&A expenses in the quarter. GAAP operating income in the fourth quarter was $107.3 million versus $104.6 million in the fourth quarter of 2020. Non-GAAP operating income in 2021 was $451 million or 8.5% of revenues compared with $390 million or 8.4% of revenues last year. GAAP operating income was $490 million versus $326 million last year. The operating expense breakdown in 2021 was as follows: Net R&D expenses were 7.5% of revenues versus 7.7% in 2020. Marketing and selling expenses declined to 5.5% of revenues versus 6.2% last year. G&A expenses were 5.1% of revenues compared with 4.8% last year. The increase in the G&A expenses was mainly related to the Sparton acquisition. While we do not provide forward guidance, I would note that the recent rise in the share price could lead to an increase in expenses in 2021 and all related to employee share price link compensation plans. Financial expenses were $20 million in the fourth quarter compared with $33 million in 2020. The lower level of financial expenses were mainly due to exchange rate differences related to the revaluation of lease liabilities in the quarter. Financial expenses in 2021 were $40 million compared to $71 million last year. We recorded the tax expense of $92.2 million in the fourth quarter compared with $1.9 million in 2020. Taxes on income in the fourth quarter included a onetime expense of approximately $80 million related to the release of exempt earnings. Please see our press release published on 22nd of February this year. We have excluded this expense from our non-GAAP net income due to the non-recurring nature of this expense. Including this extraordinary expense, the effective tax rate in 2021 was 34.3% compared with 13.9% in 2020. Our non-GAAP diluted earnings per share was $2.14 in the fourth quarter, and $8.30 for the full year of 2021. GAAP diluted EPS was $0.18 for the fourth quarter and $6.20 for the full year of 2021. Our backlog of orders as of December 31, 2021 was $13.7 billion, $2.6 billion higher than the backlog at the end of 2020. Approximately 60% of the current backlog is scheduled to be performed during 2022 and 2023. And the rest is scheduled for 2024 and beyond. The percentage of the short term backlog declined in recent years following the receipt of long term contracts improving our visibility for the future revenues. Operating cash flow for the fourth quarter was $260 million compared with $172 million in the same quarter last year. For 2021 as a whole, we reported $417 [ph] million operating cash versus $279 million in 2020. Operating cash flow benefited from receipts or delayed payments from the Israeli Ministry of Defense in the fourth quarter as well as growth in advance payments on contract by customers. The Board of Directors declared the dividend of $0.50 per share for the fourth quarter of 2021. I will now turn the call over to Mr. Machlis. Butzi, please?